| 期刊論文1. | Aarsland, D.、Andersen, K.、Larsen, J. P.、Lolk, A.、Kragh-Sørensen, P.(2003)。Prevalence and characteristics of dementia in Parkinson disease: An 8 year prospective study。Archives of Neurology,60(3),387-392。 | 2. | Aarsland, D.、Andersen, K.、Larsen, J. P.、Lolk, A.、Nielsen, H.、Kragh-Sørensen, P.(2001)。Risk of dementia in Parkinson’s disease: A community-based, prospective study。Neurology,56(6),730-736。 | 3. | Aarsland, D.、Andersen, K.、Larsen, J. P.、Perry, R.、Wentzel-Larsen, T.、Lolk, A.、Kragh-Sørensen, P.(2004)。The rate of cognitive decline in Parkinson disease。Archives of Neurology,61(12),1906-1911。 | 4. | Aarsland, D.、Ballard, C. G.、Halliday, G.(2004)。Are Parkinson’s disease with dementia and dementia with Lewy bodies the same entity?。Journal Geriatric Psychiatry Neurology,17(3),137-145。 | 5. | Aarsland, D.、Larsen, J. P.、Cummins, J. L.、Laake, K.(1999)。Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: A community-based study。Archives of Neurology,56(5),595-601。 | 6. | Aarsland, D.、Perry, R.、Larsen, J. P.、McKeith, I. G.、O'Brien, J. T.、Perry, E. K.、Ballard, C. G.(2005)。Neuroleptic sensitivity in Parkinson’s disease and parkinsonian dementias。Journal Clinical Psychiatry,66(5),633-637。 | 7. | Ballard, C. G.、Aarsland, D.、McKeith, I.、O'Brien, J.、Gray, A.、Cormack, F.、Tovee, M.(2002)。Fluctuations in attention: PD dementia vs. DLB with Parkinsonism。Neurology,59(11),1714-1720。 | 8. | Barber, R.、Ballard, C.、McKeith, I. G.、Gholkar, A.、O'Brien, J. T.(2000)。MRI volumetric study of dementia with Lewy bodies: A comparison with AD and vascular dementia。Neurology,54(6),1304-1309。 | 9. | Barber, R.、Gholkar, A.、Scheltens, P.、Ballard, C.、McKeith, I. G.、O'Brien, J. T.(1999)。Medial temporal lobe atrophy on MRI in dementia with Lewy bodies。Neurology,52(6),1153-1158。 | 10. | Barber, R.、Scheltens, P.、Gholkar, A.、Ballard, C.、McKeith, I.、Ince, P.(1999)。White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer’s disease, vascular dementia, and normal aging。Journal of Neurology Neurosurgery and Psychiatry,67(1),66-72。 | 11. | Barker, W. W.、Kashuba, A.、Luis, M.、Harwood, D. G.、Loewenstein, D.、Duara, R.(2002)。Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank。Alzheimer Disease & Associated Disorders,16(4),203-212。 | 12. | Boeve, B. F.、Ferman, T. J.、Silber, M. H.、Ferman, T. J.(2003)。Sleep disturbances in dementia with Lewy bodies involve more than REM sleep behavior disorder。Neurology,60,A79。 | 13. | Boeve, B. F., Silber, M. H., & Ferman, T. J.(20040901)。REM sleep behavior disorder in Parkinson’s disease and dementia with Lewy bodies。Journal Geriatric Psychiatry Neurology,17(3),146-157。 | 14. | Boeve, B. F.、Silber, M. H.、Parisi, J. E.、Dickson, D. W.、Ferman, T. J.、Benarroch, E. E.、Mahowald, M. W.(2003)。Synucleinopathy pathology and REM sleep behavior disorder plus dementia or Parkinsonism。Neurology,61(1),40-45。 | 15. | Bonini, N. M.、Giasson, B. I.(2005)。Snaring the function of alpha-synuclein。Cell,123(3),359-361。 | 16. | Braak, H.、Del Tredici, K.、Rub, U.、De Vos, R. A.、Jansen Steur, E. N.、Braak, E.(2003)。Staging of brain pathology related to sporadic Parkinson’s disease。Neurobiology Aging,24(2),197-211。 | 17. | Braak, H.、Rub, U.、Jansen Steur, E. N.、Del Tredici, K.、De Vos, R. A.(2005)。Cognitive status correlates with neuropathologic stage in Parkinson’s disease。Neurology,64(8),1404-1410。 | 18. | Bradshaw, J. M.、Saling, M.、Anderson, V.、Hopwood, M.、Brodtmann, A.(2006)。Higher cortical deficits influence attentional processing in dementia with Lewy bodies, relative to patients with dementia of the Alzheimer’s type and controls。Journal of Neurology Neurosurgery and Psychiatry,77(10),1129-1135。 | 19. | Burn, D. J.、Rowan, E. N.、Minnett, T.、Sanders, J.、Myint, P.、Richardson, J.、McKeith, I. G.(2003)。Extrapyramidal features in Parkinson’s disease with and without dementia and dementia with Lewy bodies: A cross-sectional comparative study。Movement Disorder,18(8),884-889。 | 20. | Burn, D. J.(2006)。Cortical Lewy body disease and Parkinson’s disease dementia。Current Opinion Neurology,19(6),572-579。 | 21. | Cahn-Weiner, D. A.、Williams, K.、Grace J.、Tremont, G.、Weatervelt, H.、Stern, R. A.(2003)。Discrimination of dementia with Lewy bodies from Alzheimer’s disease and Parkinson’s disease using the clook drawing test。Cognition Behavior Neurology,16(2),85-92。 | 22. | Caparros-Lefebvre, D.、Pechevx, N.、Petit, V.、Duhamel, A.、Petit, H.(1995)。Which factors predict cognitive decline in Parkinson’s disease?。Journal of Neurology Neurosurgery and Psychiatry,58(1),51-55。 | 23. | Chandra, S.、Gallardo, G.、Fernandez-Chacon, R.、Schlüter, O. M.、Südhof, T. C.(2005)。A lpha-synuclein cooperates with CSP alpha in preventing neurodegeneration。Cell,123(3),383-396。 | 24. | Chang, C. C.、Liu, J. S.、Chang, Y. Y.、Chang, W. N.、Chen, S. S.、Lee, C. H.(2008)。(99m)Tc-ethyl cysteinate dimer brain SPECT findings in early stage of dementia with Lewy bodies and Parkinson's disease patients: A correlation with neuropsychological tests。European Journal of Neurology,15(1),61-65。 | 25. | Chiu, M. J.,、Yi, P. K.、Yi, P. K.、Chen, T. F.、Hua, M. S.、Tang, L. Y.(2006)。Behavioral and psychologic symptoms in different types of dementia。Journal of Formosan Medical Association,105(7),556-562。 | 26. | Chui, H. C.、Mortimer, J.、A., Slager, U.、Zarow, C.、Bondareff, W.、Webster, D. D.(1986)。Pathologic correlates of dementia in Parkinson’s disease。Archives of Neurology,43(10),991-995。 | 27. | Cole, N. B.、Murphy, D. D.、Grider, T.、Rueter, S.、Brasaemle, D.、Nussbaum, R. L.(2002)。Lipid droplet binding and oligomerization properties of the Parkinson’s disease protein alpha-synuclein。Journal of Biological Chemistry,277(8),6344-6352。 | 28. | Collerton, D.、Burn, D.、McKeith, I.、Obrien, J.(2003)。Systematic review and meta-analysis show that dementia with Lewy bodies is a visual-perceptual and attentional-executive dementia。Dementia Geriatric Cognitive Disorder,16(4),229-237。 | 29. | Costa, A.、Pappe, A.、Dell’Agnello, G.、Carlesimo, G. A.、Murri, L.、Bonuccelli, U.、Caltagirone, C.(2003)。Dopaminergic modulation of visual-spatial working memory in Parkinson’s disease。Dementia Geriatric Cognitive Disorder,15(2),55-66。 | 30. | Cousins, D. A.、Burton, E. J.、Burn, D.、Gholkar, A.、McKeith, I. G.,(2003)。Atrophy of the putamen in dementia with Lewy bodies but not Alzheimer’s disease: An MRI study。An MRI study. Neurology,61(9),1191-1195。 | 31. | Donnemiller, E.、Heilmann, J.、Wenning, G. K.、Berger, W.、Decristoforo, C.、Moncayo, R.、Ransmayr, G.(1997)。Brain perfusion scintigraphy with 99mTc-HMPAO or 99mTc-ECD and 123I-bata-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease。European Journal Nuclear Medicine,24(3),320-325。 | 32. | Dubois, B.、Burn, D.、Goetz, C.,、Aarsland, D.、Brown, R. G.、Broe, G. A.、Emre, M.(2007)。Diagnostic procedures for Parkinson’s disease dementia: Recommendations for the movement disorder society take force。Movement Disorder,22(16),2314-2324。 | 33. | Edwards, K.、Royall, D.、Hershey, L.、Lichter, P. Hake, A.、Farlow, M.、Johnson, S.(2007)。Efficacy and safety of galantamine in patients with dementia with Lewy bodies: A 24-week open-label study。Dementia Geriatric Cognitive Disorder,23(6),401-405。 | 34. | Emre, M.、Aarsland, D.、Brown, R.、Burn, D. J.、Duyckaerts, C.、Mizuno, Y.、Dubois, B.(2007)。Clinical diagnostic criteria for dementia associated with Parkinson’s disease。Movement disorder,22(12),1689-1707。 | 35. | Ferman, T. J.、Smith, G. E.、Boeve, B. F.、Ivnik, R. J.、Petersen, R. C.、Knopman, D.、Dickson, D. W.(2004)。DLB fluctuations: Specific features that reliably differentiate DLB from AD and normal aging。Neurology,62(2),181-187。 | 36. | Fernandez, H. H.、Trieschmann, M. E.、Burke, M. A.、Friedman, J. H.(2002)。Quetiapine for psychosis in Parkinson’s disease versus dementia with Lewy bodies。Journal Clinical Psychiatry,63(6),513-515。 | 37. | Fernandez, H. H.、Trieschmann, M. E.、Burke, M. A.、Jacques, C.、Friedman, J. H.(2003)。Long-term outcome of quetiapine use for psychosis among Parkinsonian patients。Movement Disorder,18(5),510-514。 | 38. | Forsberg, A.、Engler, H.、Almkvist, O.、Blomquist, G.、Hagman, G.、Wall, A.、Nordberg, A.(2008)。PET imaging of amyloid deposition in patients with mild cognitive impairment。Neurobiology Aging,29(10),1456-1465。 | 39. | Galvin, J. E.(2006)。Cognitive change in Parkinson disease。Alzheimer Disease Association Disorder,20(4),302-310。 | 40. | Galvin, J. E.、Lee, V. CM.、Trojanowski, J. Q.(2001)。Synucleinopathies: Clinical and pathological implications。Archives Neurology,58(2),186-190。 | 41. | Galvin, J. E.、Pollack, J.、Morris, J. C.(2006)。Clinical phenotype of Parkinson disease dementia。Neurology,67(9),1605-1611。 | 42. | Gaspar, P.、Gray, F.(1984)。Dementia in idiopathic Parkinson’s disease: A neuropathological study of 32 cases。Acta Neuropathological,64(1),43-52。 | 43. | George, J. M.、Jin, H.、Woods, W. S.、Clayton, D. F.(1995)。Characterization of a novel protein regulated during the critical period for song learning in the zebra finch。Neuron,15(2),361-372。 | 44. | Gjerstad, M. D.、Aarsland, D.、Larsen, J. P.(2002)。Development of daytime somnolence overtime in Parkinson’s disease。Neurology,58(10),1544-1546。 | 45. | Han, H.、Weinreb, P. H.、Lansbury, P. T.(1995)。The core A lzheimer’s peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid: Is NA C a common trigger or target in neurodegenerative disease?。Chemical Biology,2(3),163-169。 | 46. | Harding, A. J.、Broe, G. A.、Halliday, G. M.(2002)。Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe。Brain,125(Pt2),391-403。 | 47. | Henderson, R.、Kurlan, R.、Kersun, J. M.、Como, P. G.(1992)。Preliminary examination of the comorbidity of anxiety and depression in Parkinson’s disease。Journal Neuropsychiatry Clinical Neuroscience,4(3),257-264。 | 48. | Higuchi, M.、Tashiro, M.、Arai, H.、Okamura, N.、Hara, S.、Higuchi, S.、Sasaki, H.(2000)。Glucose hypometabolis m and neuropathological correlates in brains of dementia with Lewy bodies。Experimental Neurology,162(2),247-256。 | 49. | Hsiao, I. -T.、Huang, C. -C.、Hsieh, C. -J.、Hsu, W. -C.、Wey, S. -P.、Yen, T. -C.、Lin, K. -J.(2012)。Correlation of early-phase F-18 Florbetapir (A V-45/Amyvid) PET images to FDG images: Preliminary studies。European Journal of nuclear medicine and molecular imaging,39(4),613-620。 | 50. | Hu, X. S.、Okamura, N.、Arai, H.、Higuchi, M.、Matsui, T.、Tashiro, M.、Sasaki, H.(2000)。18F-fluorodopa PET study of striatal dopamine uptake in the diagnosis of dementia with Lewy bodies。Neurology,55(10),1575-1577。 | 51. | Hughes, T. A.、Ross, H. F.、Musa, S.、Bhattacherjee, S.、Nathan, R. N.、Mindham, R. H.、Spokes, E. G.(2000)。A 10-year study of the incidence and factors predicting dementia in Parkinson’s disease。Neurology,54(8),1596-1602。 | 52. | Jakes, R.、Spillantini, M. G.、Goedert, M.(1994)。Identification of two distinct synucleins from human brain。FEBS Letters,345(1),27-32。 | 53. | Janvin, C. C.、Larsen, J. P.、Salmon, D. P.、Galasko, D.、Hugdahl, K.、Aarsland, D.(2006)。Cognitive profiles of individual patients with Parkinson’s disease and dementia: Comparison with dementia with Lewy bodies and Alzheimer’s disease。Movement Disorder,21(3),337-342。 | 54. | Ji, H.、Liu, Y. E.、Jia, T.、Wang, M.、Liu, J.、Xiao, G.、Shi, Y. E.(1997)。Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing。Cancer Research,57(4),759-764。 | 55. | Johnson, D. K.、Morris, J. C.、Galvin, J. E.(2005)。Verbal and visuospatial deficits in dementia with Lewy bodies。Neurology,65(8),1232-1238。 | 56. | Kenny, R. A.、Kalaria, R.、Ballard, C.(200211)。Neurocardiovascular instability in cognitive impairment and dementia。Annals of the New York Academy Sciences,977,183-195。 | 57. | Kenny, R. A.、Shaw, F. E.、O’Brien, J. T.、Scheltens, P. H.、Kalaria, R.、Ballard, C.(2004)。Carotid sinus syndrome is common in dementia with Lewy bodies and correlates with deep white matter lesions。Journal of Neurology Neurosurgery and Psychiatry,75(7),966-971。 | 58. | Klatka, L. A.、Louis, E. D.、Schiffer, R. B.(1996)。Psychiatric features in diffuse Lewy body disease: A clinicopathologic study using Alzheimer’s disease and Parkinson’s disease comparison groups。Neurology,47(5),1148-1152。 | 59. | Klunk, W. E.、Engler, H.、Nordberg, A.、Wang, Y.、Blomqvist, G.、Holt, D. P.、Långström, B.(2004)。Imaging brain amyloid in A lzheimer’s disease with Pittsburgh compound-β。Annals of Neurology,55(3),306-319。 | 60. | Kosaka, K.(1990)。Diffuse Lewy body disease in Japan。Journal of Neurology,237(3),197-204。 | 61. | Kosaka, K.、Matsushita, M.、Oyanagi, S.、Mehraein, P.(1980)。A clinicopathological study of the Lewy body disease。Psychiatric Neurology Japanica,82(5),292-311。 | 62. | Kovari, E.、Gold, G.、Herrmann, F. R.、Canuto, A.、Hof, P. R.、Bouras, C.、Giannakopoulos, P.(2003)。Lewy body densities in the entorhinal and anterior cingulated cortex predict cognitive deficits in Parkinson’s disease。Acta Neuropathologica,106(1),83-88。 | 63. | Kuzis, G.、Sabe, L.、Tiberti, C.、Leiguarda, R.、Starkstein, S. E.(1997)。Cognitive functions in major depression and Parkinson’s disease。Archives of Neurology,54(8),982-986。 | 64. | Lees, A. J.、Smith, E.(1983)。Cognitive deficits in the early stages of Parkinson's disease。Brain,106(part 2),257-270。 | 65. | Lavedan, C.、Leroy, E.、Dehejia, A.、Buchholtz, S.、Dutra, A.、Nussbaum, R. L.、Polymeropoulos, M. H.(1998)。Identification, localization and characterization of the human gamma-synuclein gene。Human Genetics,103(1),106-112。 | 66. | Lee, W. -J.、Tsai, C. -F.、Wang, S. -J.、Gauthier, Serge(201212)。The association between cognitive impairment and neuropsychiatric symptoms in patients with Parkinson’s disease dementia。International Psychogeriatrry,24(12),1980-1987。 | 67. | Levin, B. E.、Llabre, M. M.、Weiner, W. J.(1989)。Cognitive impairments associated with early Parkinson's disease。Neurology,39(4),557-561。 | 68. | Lin, K. J.、Hsu, W. C.、Hsiao, I. T.、Wey, S. P.、Jin, L. W.、Skovronsky, D.、Kung, M. P.(2010)。Whole body biodistribution and brain PET imaging with [18F] AV-45, a novel amyloid imaging agent-a pilot study。Nuclear Medicine Biology,37(4),497-508。 | 69. | Lippa, C. F.、Duda, J. E.、Grossman, M.、Hurtig, H. I.、Aarsland, D.、Boeve, B. F.、Wszolek, Z. K.(2007)。DLB and PDD boundary issues: Diagnosis, treatment, molecular pathology, and biomarkers。Neurology,68(11),812-819。 | 70. | Litvan, I.、Goldman, J. G.、Tröster, A. I.、Schmand, B. A.、Weintraub, D.、Petersen, R. C.、Emre, M.(201203)。Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines。Mov Disord,27(3),349-356。 | 71. | Liu, C. -K.、Lai, C. -L.、Tai, C. -T.、Lin, R. -T.、Yen, Y. -Y.、Howng, S. -L.(1998)。Incidence and subtypes of dementia in southern Taiwan impact of socio-demographic factors。Neurology,50(6),1572-1579。 | 72. | Louis, E. D.、Klatka, L. A.、Liu, Y.、Fahn, S.(1997)。Comparison of extrapyramidal features in 31 pathologically confirmed cases of diffuse Lewy body disease and 34 pathologically confirmed cases of Parkinson's disease。Neurology,48(2),376-380。 | 73. | Martí, M. J.、Tolosa, E.、Campdelacreu, J.(2003)。Clinical overview of the synucleinopathies。Movement Disorder,18(Suppl 6),S21-S27。 | 74. | Mathis, C. A.、Backskai, B. J.、Kajdasz, S. T.、McLellan, M. E.、Frosch, M. P.、Hyman, B. T.、Klunk, W. E.(2002)。A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain。Bioorganic&Medicinal Chemistry Letters,12(3),295-298。 | 75. | Matsui, H.、Udaka, F.、Miyoshi, T.、Hara, N.、Tamura, A.、Oda, M.、Kameyama, M.(2005)。N-isopropyl-p-123I iodoamphetamine single photon emission computed tomography study of Parkinson's disease with dementia。International Medicine,44(10),1046-1050。 | 76. | McKeith, I. G.(2000)。Spectrum of Parkinson's disease, Parkinson's dementia, and Lewy body dementia。Neurologic Clinic,18(4),865-902。 | 77. | McKeith, I. G.(2007)。Dementia with Lewy Bodies and Parkinson’s disease with dementia: Where two world collide。Practical Neurology,7(6),374-382。 | 78. | McKeith, I.、Del Ser, T.、Spano, P.、Emre, M.、Wesnes, K.、Anand, R.、Spiegel, R.(2000)。Efficacy of rivastigmine in dementia with Lewy bodies: A randomised, double-blind, placebo-controlled international study。Lancet,356(9247),2031-2036。 | 79. | McKeith, I.、Mintzer, J.、Aarsland, D.、Burn, D.、Chiu, H.、Cohen-Wansfield, J.、Reid, W.(2004)。Dementia with Lewy bodies。Lancet Neurology,3(1),19-28。 | 80. | McKeith, I. G.、Ballard, C. G.、Perry, R. H.、Ince, P. G.、O'Brien, J. T.、Neill, D.、Perry, E. K.(2000)。Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies。Neurology,54(5),1050-1058。 | 81. | McKeith, I. G.、Dickson, D. W.、Lowe, J.、Emre, M.、O'Brien, J. T.、Feldman, H.、Yamada, M.(2005)。Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium。Neurology,65(12),1863-1872。 | 82. | McKeith, I. G.、Fairbairn, A. F.、Perry, R. H.,、Thompson, P.(1994)。The clinical diagnosis and misdiagnosis of senile dementia of Lewy body type (SDLT)。British Journal of Psychiatry,165(3),324-332。 | 83. | McKeith, I. G.、Galasko, D.、Kosaka, K.、Perry, E. K.、Dickson, D. W.、Hansen, L. A.、Perry, R. H.(1996)。Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop。Neurology,47(5),1113-1124。 | 84. | McKeith, I. G.、Perry, R. H.、Fairbairn, A. F.、Jabeen, S.、Perry, E. K.(1992)。Operational criteria for senile dementia of Lewy body type (SDLT)。Psychological Medicine,22(4),911-922。 | 85. | McKeith, I. G.、Wesnes, K. A.、Perry, E.、Ferrara, R.(2004)。Halluc inations predict attentional improvements with rivastigmine in dementia with lewy bodies。Dementia Geriatric Cognitive Disorder,18(1),94-100。 | 86. | Meco, G.、Bonifati, V.、Cusimano, G.、Fabrizio, E.、Vanacore, N.(1990)。Hallucinations in Parkinson disease: Neuropsychological study Ital。Journal of the Neurologic Sciences,11(4),373-379。 | 87. | Menza, M. A.、Robertson-Hoffman, D. E.、Bonapace, A. S.(1993)。Parkinson's disease and anxiety: Comorbidity with depression。Biological Psychiatry,34(7),465-470。 | 88. | Monsch, A. U.、Bondi, M. W.、Butters, N.、Salmon, D. P.、Katzman, R.、Thal, L. J.(1992)。Comparisons of verbal fluency tasks in the detection of dementia of the alzheimer type。Arch Neurol,49(12),1253-1258。 | 89. | Molloy, S.、McKeith, I. G.、O'Brien, J. T.、Burn, D. J.(2005)。The role of L-dopa in the management of dementia with Lewy bodies。Journal of Neurology Neurosurgery and Psychiatry,76(9),1200-1203。 | 90. | Mori, E.、Shimomura, T.、Fujimori, M.、Hirono, N.、Ima mura, T.、Hashimoto, M.、Hanihara, T.(2000)。Visuoperceptual impairment in dementia with Lewy bodies。Archives of Neurolgy,57(4),489-493。 | 91. | Mosimann, U. P.、Mather, G.、Wesnes, K. A.、O'Brien, J. T.、Burn, D. J.、McKeith, I. G.(2004)。Visual perception in Parkinson disease dementia and dementia with Lewy bodies。Neurology,63(11),2091-2096。 | 92. | Murphy, D. D.、Rueter, S. M.、Trojanowski, J. Q.、Lee, V. M.(2000)。Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons。Journal of the Neurologic Sciences,20(9),3214-3220。 | 93. | Ninkina, N. N.、A limova-Kost, M. V.、Paterson, J. W.、Delaney, L.、Cohen, B. B.、Imreh, S.、Buchman, V. L.(1998)。Organization, expression and polymorphis m of the human persyn gene。Human Molecular Genetics,7(9),1417-1424。 | 94. | Okereke, C. S.、Kirby, L.、Kumar, D.、Cullen, E. I.、Pratt, R. D.、Hahne, W. A.(2004)。Concurrent administration of donepezil HCl and L-dopa/carbidopa in patients with Parkinson's disease: Assessment of pharmacokinetic changes and safety following multiple oral doses。British Journal of Clinical Pharmacology,58(S1),41-49。 | 95. | Orskov, L.、Jakobsen, J.、Dupont, E.、De Fine Olivarius, B.、Christensen, N. J.(1987)。Autonomic function in parkinsonian patients relates to duration of disease。Neurology,37(7),1173-1178。 | 96. | Owen, A. M.、Roberts, A. C.、Hodges, J. R.、Summers, B. A.、Polkey, C. E.、Robbins, T. W.(1993)。Contrasting mechanis ms of impaired attentional set-shifting in patients with frontal lobe damage or Parkinson's disease。Brain,116 (Pt5),1159-1175。 | 97. | Polymeropoulos, M. H.、Lavedan, C.、Leroy, E.、Ide, S. E.、Dehejia, A.、Dutra, A.、Nussbaum, R, L.(1997)。Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease。Science,276(5321),2045-2047。 | 98. | Price, J. C.、Kleenk, W. E.、Lopresti, B. J.、Lu, X.、Hoge, J. A.、Ziolko, S. K.、Mathis, C. A.(2005)。Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh compound-β。Journal Cerebral Blood flow metabolism,25(11),1528-1547。 | 99. | Rahkonen, T.、Eloniemi-Sulkava, U.、Rissanen, S.、Vatanen, A.、Viramo, P.、Sulkava, R.(2003)。Dementia with Lewy bodies according to the consensus criteria in a general population aged 75 years or older。Neurosurgery, and Psychiatry,74(6),720-724。 | 100. | Ramakrishnan, M.、Jensen, P. H.、Marsh, D.(2003)。A lpha-synuclein association with phosphatidylglycerol probed by lipid spin labels。Biochemistry,42(44),12919-12926。 | 101. | Ridha, B. H.、Josepha, K. A.、Rossor, M. N.(2005)。Delusions and hallucinations in dementia with Lewy bodies: Worsening with memantine。Neurology,65(3),481-482。 | 102. | Rodriguez-Fernandez, A.、Gomez-Rio, M.、Carnero, C.(1998)。Regional cerebral blood flow in patients with dementia with Lewy bodies。Neurobiology Aging,19,S205。 | 103. | Rowe, C. C.、Ng, S., Ackermann, U.、Gong,S. J.、Pike, K.、Savage, G.、Villemagne, V. L.(2007)。Imaging beta-amyloid burden in aging and dementia。Neurology,68(20),1718-1725。 | 104. | Sabbagh, M. N.、Hake, A. M.、Ahmed, S.、Farlow, M. R.(2005)。The use of memantine in dementia with Lewy bodies。Journal of Alzheimer’s Disease,7(4),285-289。 | 105. | Salmon, D. P.、Galasko, D.、Hansen, L. A.、Masliah, E.、Butters, N.、Thal, L. J.、Katzman, R.(1996)。Neuropsychological deficits associated with diffuse Lewy body disease。Brain and Cognition,31(2),148-165。 | 106. | Sano, M.、Stern, Y.、W illiams, J.、Cote, L.、Rosenstein, R.、Mayeux, R.(1989)。Coexisting dementia and depression in Parkinson’s disease。Archives of Neurology,46(12),1284-1286。 | 107. | Senard, J. M.、Rai, S.、Lapeyre-Mestre, M.、Brefel, C.、Rascol, O.、Rascol, A.、Montastruc, J. L.(1997)。Prevalence of orthostatic hypotension in Parkinson’s disease。Journal of Neurology Neurosurgery and Psychiatry,63(5),584-589。 | 108. | Sharon, R.、Bar-Joseph, I.、Mirick, G. E.、Serhan, C. N.、Selkoe, D. J.(2003)。Altered fatty acid composition of dopaminergic neurons expressing alpha-synuclein and human brains with alpha-synucleinopathies。Journal of Biological Chemistry,278(50),49874-49881。 | 109. | Shimizu, S.、Hanyu, H.、Kanetaka, H.、Iwamoto, T.、Koizumi, K.、Abe, K.(2005)。Differentiation of dementia with Lewy bodies from Alzheimer’s disease using brain SPECT。Dementia Geriatric Cognitive Disorder,20(1),25-30。 | 110. | Spillantini, M. G.、Divane, A.、Goedert, M.(1995)。Assignment of human alpha-synuclein (SNCA) and beta-synuclein (SNCB) genes to chromosomes 4q21 and 5q35。Genomics,27(2),379-381。 | 111. | Stevens, T.、Livingston, G.、Kitchen, G.、Manela, M.、Walker, Z.、Katona, C.(2002)。Islington study of dementia subtypes in the community。British Journal of Psychiatry,180(3),270-276。 | 112. | Tobe, T.、Nakajo, S.、Tanaka, A.、Mitoya, A.、Omata, K.、Nakaya, K.、Nakamura, Y.(1992)。Cloning and characterization of the cDNA encoding a novel brain-specific 14-kDa protein。Journal of Neurochemistry,59(5),1624-1629。 | 113. | Touchon, J.、Bergman, H.、Bullock, R.、Rapatz, G.、Nagel, J.、Lane, R.(2006)。Response to rivastigmine or donepezil in A lzheimer’s patients with symptoms suggestive of concomitant Lewy body pathology。Current Medical Reseach Opinion,22(1),49-59。 | 114. | Tsuboi, Y.、Dickson, D. W.(2005)。Dementia with Lewy bodies and Parkinson’s disease with dementia: Are they different。Parkinsonism and Related Disorders,11(S1),S47-S51。 | 115. | Verhoeff, N. P.、Wilson, A. A.、Takeshita, S.、Trop, L.、Hussey, D.、Singh, K.、Houle, S.(2004)。In -vivo imaging of Alzheimer’s disease beta-amyloid with〔11C〕-SB13PET。American Journal Geriatric Psychiatry,12(6),584-595。 | 116. | Walker, Z.、Graces, J.、Overshot, R.、Satarasinghe, S.、Swan, A.、Katona, C. L.、McKeith, I. G.(1999)。Olanzapine in dementia with Lewy bodies: A clinical study。International Journal of Geriatric Psychiatry,14(6),459-466。 | 圖書1. | Parkinson, J.(1817)。An essay on the shaking palsy。London:Sherwood, Neely and Jones。 | |